VP3.15 dihydrobromide is primarily utilized in research settings, particularly in the study of neurodegenerative diseases. It has shown potential in modulating pathways associated with Alzheimer's disease, making it a valuable compound for investigating therapeutic interventions. Its application extends to preclinical studies where it is used to explore its neuroprotective effects and its ability to reduce amyloid-beta plaque formation. Additionally, it serves as a tool compound in pharmacological research to better understand the mechanisms underlying cognitive decline and neuronal damage. Its role in targeting specific molecular pathways makes it a promising candidate for developing treatments aimed at mitigating the progression of neurodegenerative conditions.